The effect of protein corona composition on the interaction of carbon nanotubes with human blood platelets

Biomaterials

Volumn 35, Issue 24, 2014, Pages 6182-6194

  De Paoli, Silvia H ^a   Diduch, Lukas L ^c   Tegegn, Tseday Z ^a   Orecna, Martina ^a   Strader, Michael B ^a   Karnaukhova, Elena ^a   Bonevich, John E ^c   Holada, Karel ^b   Simak, Jan ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b CHARLES UNIVERSITY   (Czech Republic)

^c NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

Author keywords

Biocompatibility; Carbon nanotubes; Nanoparticles; Nanotoxicity; Platelets; Protein corona

Indexed keywords

BIOCOMPATIBILITY; CARBON NANOTUBES; MULTIWALLED CARBON NANOTUBES (MWCN); NANOPARTICLES; NANOSTRUCTURED MATERIALS; PLATELETS;

BIOLOGICAL PROPERTIES; HUMAN PROTEINS; MICRO-PARTICLES; NANOTOXICITY; NON-COVALENT INTERACTION; PLATELET MEMBRANES; PROTEIN CORONAS; SAFETY ISSUES;

PROTEINS;

CARBON NANOTUBE; LACTATE DEHYDROGENASE; PLASMA PROTEIN; PROTEIN BINDING; PROTEOME; REACTIVE OXYGEN METABOLITE;

ANIMAL; BOVINAE; CHEMICAL STRUCTURE; CHEMISTRY; CIRCULAR DICHROISM; HUMAN; METABOLISM; SURFACE PROPERTY; THROMBOCYTE; THROMBOCYTE ACTIVATION; ULTRASTRUCTURE;

ANIMALS; BLOOD PLATELETS; BLOOD PROTEINS; CATTLE; CIRCULAR DICHROISM; HUMANS; L-LACTATE DEHYDROGENASE; MODELS, MOLECULAR; NANOTUBES, CARBON; PLATELET ACTIVATION; PROTEIN BINDING; PROTEOME; REACTIVE OXYGEN SPECIES; SURFACE PROPERTIES;

EID: 84901468502     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.04.067     Document Type: Article

References (54)

1. Foldvari M., Bagonluri M. Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues. Nanomed Nanotechnol 2008, 4:183-200.
2. Hirata E., Menard-Moyon C., Venturelli E., Takita H., Watari F., Bianco A., et al. Carbon nanotubes functionalized with fibroblast growth factor accelerate proliferation of bone marrow-derived stromal cells and bone formation. Nanotechnology 2013, 24:435101.
3. Hu H., Ni Y.C., Montana V., Haddon R.C., Parpura V. Chemically functionalized carbon nanotubes as substrates for neuronal growth. Nano Lett 2004, 4:507-511.
4. Iverson N.M., Barone P.W., Shandell M., Trudel L.J., Sen S., Sen F., et al. Invivo biosensing via tissue-localizable near-infrared-fluorescent single-walled carbon nanotubes. Nat Nanotechnol 2013, 8:873-880.
5. Madani S.Y., Naderi N., Dissanayake O., Tan A., Seifalian A.M. Anew era of cancer treatment: carbon nanotubes as drug delivery tools. Int J Nanomed 2011, 6:2963-2979.
6. De La Zerda A., Zavaleta C., Keren S., Vaithilingam S., Bodapati S., Liu Z., et al. Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat Nanotechnol 2008, 3:557-562.
7. Parpura V. Instrumentation: carbon nanotubes on the brain. Nat Nanotechnol 2008, 3:384-385.
8. Williams D.F. On the mechanisms of biocompatibility. Biomaterials 2008, 29:2941-2953.
9. Tenzer S., Docter D., Kuharev J., Musyanovych A., Fetz V., Hecht R., et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol 2013, 8:772-U1000.
10. Monopoli M.P., Aberg C., Salvati A., Dawson K.A. Biomolecular coronas providethe biological identity of nanosized materials. Nat Nanotechnol 2012, 7:779-786.
11. Salvati A., Pitek A.S., Monopoli M.P., Prapainop K., Bombelli F.B., Hristov D.R., et al. Transferrin-functionalized nanoparticles lose their targeting capabilities whena biomolecule corona adsorbs on the surface. Nat Nanotechnol 2013, 8:137-143.
12. Wang X., Xia T., Duch M.C., Ji Z., Zhang H., Li R., et al. Pluronic F108 coating decreases the lung fibrosis potential of multiwall carbon nanotubes by reducing lysosomal injury. Nano Lett 2012, 12:3050-3061.
13. Sacchetti C., Motamedchaboki K., Magrini A., Palmieri G., Mattei M., Bernardini S., et al. Surface polyethylene glycol conformation influences the protein corona of polyethylene glycol-modified single-walled carbon nanotubes: potential implications on biological performance. ACS Nano 2013, 7:1974-1989.
14. Lacerda S.H.D., Semberova J., Holada K., Simakova O., Hudson S.D., Simak J. Carbon nanotubes activate store-operated calcium entry in human blood platelets. ACS Nano 2011, 5:5808-5813.
15. + influx sensitive to calcium entry inhibitors. Nano Lett 2009, 9:3312-3317.
16. Vakhrusheva T.V., Gusev A.A., Gusev S.A., Vlasova I.I. Albumin reduces thrombogenic potential of single-walled carbon nanotubes. Toxicol Lett 2013, 221:137-145.
17. Ge C., Du J., Zhao L., Wang L., Liu Y., Li D., et al. Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc Natl Acad Sci U S A 2011, 108:16968-16973.
18. Semple J.W., Italiano J.E., Freedman J. Platelets and the immune continuum. Nat Rev Immunol 2011, 11:264-274.
19. Luong J.H., Male K.B., Mahmoud K.A., Sheu F.S. Purification, functionalization, and bioconjugation of carbon nanotubes. Methods Mol Biol 2011, 751:505-532.
20. Hu W.J., Eaton J.W., Ugarova T.P., Tang L. Molecular basis of biomaterial-mediated foreign body reactions. Blood 2001, 98:1231-1238.
21. Leszczak V., Smith B.S., Popat K.C. Hemocompatibility of polymeric nanostructured surfaces. JBiomater Sci Polym Ed 2013, 24:1529-1548.
22. Semeraro F., Ammollo C.T., Morrissey J.H., Dale G.L., Friese P., Esmon N.L., et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood 2011, 118:1952-1961.
23. Orecna M., De Paoli S.H., Janouskova O., Tegegn T.Z., Filipova M., Bonevich J.E., et al. Toxicity of carboxylated carbon nanotubes in endothelial cells is attenuated by stimulation of the autophagic flux with the release of nanomaterial in autophagic vesicles. Nanomedicine 2014, [Available online 22 February 2014].
24. Ling W.L., Biro A., Bally I., Tacnet P., Deniaud A., Doris E., et al. Proteins of the innate immune system crystallize on carbon nanotubes but are not activated. ACS Nano 2011, 5:730-737.
25. Kollman J.M., Pandi L., Sawaya M.R., Riley M., Doolittle R.F. Crystal structure of human fibrinogen. Biochemistry 2009, 48:3877-3886.
26. Sugio S., Kashima A., Mochizuki S., Noda M., Kobayashi K. Crystal structure ofhuman serum albumin at 2.5 angstrom resolution. Protein Eng 1999, 12:439-446.
27. Saphire E.O., Parren P.W.H.I., Pantophlet R., Zwick M.B., Morris G.M., Rudd P.M., et al. Crystal structure of a neutralizing human IgG against HIV-1: a template for vaccine design. Science 2001, 293:1155-1159.
28. Donev R. Organisation of chromosomes, advances in protein chemistry and structural biology 2013, Academic Press.
29. Baker N.A., Sept D., Joseph S., Holst M.J., McCammon J.A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci U S A 2001, 98:10037-10041.
30. Dolinsky T.J., Nielsen J.E., McCammon J.A., Baker N.A. PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res 2004, 32:W665-W667.
31. Simak J., Holada K., Janota J., Stranak Z. Surface expression of major membrane glycoproteins on resting and TRAP-activated neonatal platelets. Pediatr Res 1999, 46:445-449.
32. Lacerda S.H., Park J.J., Meuse C., Pristinski D., Becker M.L., Karim A., et al. Interaction of gold nanoparticles with common human blood proteins. ACS Nano 2010, 4:365-379.
33. Roach P., Farrar D., Perry C.C. P31. NS1. P5. Interpretation of protein adsorption: surface-induced conformational changes. JAm Chem Soc 2005, 127:8168-8173.
34. Chen B., Liu Y., Song W.M., Hayashi Y., Ding X.C., Li W.H. Invitro evaluation of cytotoxicity and oxidative stress induced by multiwalled carbon nanotubes in murine RAW 264.7 macrophages and human A549 lung cells. Biomed Environ Sci 2011, 24:593-601.
35. Bode A.P., Orton S.M., Frye M.J., Udis B.J. Vesiculation of platelets during invitro aging. Blood 1991, 77:887-895.
36. Guo L., Von Dem Bussche A., Buechner M., Yan A., Kane A.B., Hurt R.H. Adsorption of essential micronutrients by carbon nanotubes and the implications for nanotoxicity testing. Small 2008, 4:721-727.
37. Wu X.C., Zhang W.J., Sammynaiken R., Meng Q.H., Yang Q.Q., Zhan E., et al. Non-functionalized carbon nanotube binding with hemoglobin. Colloids Surf B Biointerfaces 2008, 65:146-149.
38. Kutcher M.E., Xu J., Vilardi R.F., Ho C., Esmon C.T., Cohen M.J. Extracellular histone release in response to traumatic injury: implications for a compensatory role of activated protein C. JTrauma Acute Care Surg 2012, 73:1389-1394.
39. Deng Z.J., Liang M.T., Monteiro M., Toth I., Minchin R.F. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat Nanotechnol 2011, 6:39-44.
40. Dave Nelson M.C. Lehninger principles of biochemistry 2008, W H Freeman & Co. 5th ed.
41. Wang S., Humphreys E.S., Chung S.Y., Delduco D.F., Lustig S.R., Wang H., et al. Peptides with selective affinity for carbon nanotubes. Nat Mater 2003, 2:196-200.
42. Liu J., Yang L., Hopfinger A.J. Affinity of drugs and small biologically active molecules to carbon nanotubes: a pharmacodynamics and nanotoxicity factor?. Mol Pharm 2009, 6:873-882.
43. Akdogan Y., Reichenwallner J., Hinderberger D. Evidence for water-tuned structural differences in proteins: an approach emphasizing variations in local hydrophilicity. PloS One 2012, 7:e45681.
44. Gun'ko V.M., Turov V.V. Nuclear magnetic resonance studies of interfacial phenomena 2013, CRC Press.
45. Demeule B., Gurny R., Arvinte T. Where disease pathogenesis meets protein formulation: renal deposition of immunoglobulin aggregates. Eur J Pharm Biopharm 2006, 62:121-130.
46. Yang M., Meng J., Mao X.B., Yang Y., Cheng X.L., Yuan H., et al. Carbon nanotubes induce secondary structure changes of bovine albumin in aqueous phase. JNanosci Nanotechnol 2010, 10:7550-7553.
47. Park S.J., Khang D. Conformational changes of fibrinogen in dispersed carbon nanotubes. Int J Nanomed 2012, 7:4325-4333.
48. Deng J., Sun M.C., Zhu J.Y., Gao C.Y. Molecular interactions of different size AuNP-COOH nanoparticles with human fibrinogen. Nanoscale 2013, 5:8130-8137.
49. Nonckreman C.J., Fleith S., Rouxhet P.G., Dupont-Gillain C.C. Competitive adsorption of fibrinogen and albumin and blood platelet adhesion on surfaces modified with nanoparticles and/or PEO. Colloids Surf B Biointerfaces 2010, 77:139-149.
50. Goncalves I.C., Martins M.C., Barbosa M.A., Naeemi E., Ratner B.D. Selective protein adsorption modulates platelet adhesion and activation to oligo(ethylene glycol)-terminated self-assembled monolayers with C18 ligands. JBiomed Mater Res A 2009, 89:642-653.
51. Antczak A.J., Singh N., Gay S.R., Worth R.G. IgG-complex stimulated platelets: a source of sCD40L and RANTES in initiation of inflammatory cascade. Cell Immunol 2010, 263:129-133.
52. Endresen G.K., Forre O. Studies on the binding of immunoglobulins and immune complexes to the surface of human platelets: IgG molecules react with platelet Fc receptors with the CH3 domain. Int Arch Allergy Appl Immunol 1982, 67:33-39.
53. Lian E.C., Mui P.T., Siddiqui F.A., Chiu A.Y., Chiu L.L. Inhibition of platelet-aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G. JClin Invest 1984, 73:548-555.
54. Karas S.P., Rosse W.F., Kurlander R.J. Characterization of the IgG-Fc receptor on human platelets. Blood 1982, 60:1277-1282.